FDA issues complete response for once-monthly aripiprazole
13:48 EDT 27 Jul 2012 | BioCentury
Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) and partner H. Lundbeck A/S (CSE:LUN) said FDA issued a complete response letter for an NDA for a once-monthly depot formulation of aripiprazole for the maintenance treatment of schizophrenia. The pharma..
Original Article: FDA issues complete response for once-monthly aripiprazole
More From BioPortfolio on "FDA issues complete response for once-monthly aripiprazole"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
